Pangaea Oncology S.A. Strategic Asset Allocation Index
Pangaea Oncology S.A. strategic asset allocation index. Pangaea Oncology S.A. (PANG) has a Strategic Asset Allocation Index of 1.5% as of December 2022. Strategic assets (PP&E of €352.52K plus long-term investments of €-) total €352.52K, measured against net assets of €23.08 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PANG equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Pangaea Oncology S.A. (2020–2022)
Strategic asset allocation index of Pangaea Oncology S.A. from 2020 to 2022. This chart shows how Pangaea Oncology S.A.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 1.5%, representing strategic assets of €352.52K against net assets of €23.08 Million EUR. Check Pangaea Oncology S.A. (PANG) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Pangaea Oncology S.A. Strategic Asset Allocation Index by Year (2020–2022)
Pangaea Oncology S.A. strategic asset allocation index by year from 2020 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Pangaea Oncology S.A. from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PANG stock market capitalisation.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.5% | €352.52K | €352.52K | €- | €23.08 Million | ▼ -1.5 pp |
| 2021 | 3.0% | €429.41K | €429.41K | €- | €14.09 Million | ▼ -3.4 pp |
| 2020 | 6.5% | €553.07K | €553.07K | €- | €8.57 Million | — |